IL-6, TNF-α, IL-1β, and IFN-γ Cytokines as Core Inflammatory Biomarkers: Biological Roles, Diagnostic Utility, and Clinical Applications

Abstract

Cytokines are pivotal mediators of intercellular communication in immunity and inflammation, exerting their effects through tightly regulated signaling cascades that shape both innate and adaptive responses. Among them, interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ) represent key biomarkers that orchestrate distinct yet interconnected phases of the inflammatory process. This review synthesizes current evidence on the molecular mechanisms, functional roles, and clinical significance of these four cytokines. IL-1β and TNF-α act as early pro-inflammatory mediators, initiating vascular activation, leukocyte recruitment, and febrile responses. IL-6 sustains acute-phase reactions and bridges innate and adaptive immunity, while IFN-γ enhances antimicrobial defenses and antigen presentation, shaping T-cell polarization. Advances in detection methods—including ELISA, multiplex immunoassays, high-sensitivity biosensors, and IFN-γ release assays—have enabled precise quantification, improving diagnostic accuracy, disease monitoring, and therapeutic decision-making across a broad spectrum of autoimmune, infectious, cardiovascular, and neoplastic disorders. Clinically, elevated cytokine levels serve as diagnostic discriminators, prognostic markers, and guides for targeted therapies such as anti-TNF and anti-IL-6 biologics. Conclusion: IL-1β, IL-6, TNF-α, and IFN-γ emerge as indispensable biomarkers whose measurement provides critical insights into disease pathogenesis and underpins the advancement of personalized medicine in inflammatory conditions.